A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous Improvements of outcomes after an autologous cartilage tissue implantation, compared with microfracture for treatment of distal femoral cartilage lesions.

Grigoriadis Ioannis

doi:10.5281/zenodo.34625

Published December 3, 2015 | Version v1

Journal article Restricted

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous Improvements of outcomes after an autologous cartilage tissue implantation, compared with microfracture for treatment of distal femoral cartilage lesions.

Grigoriadis Ioannis¹

1. Biogenea Pharmaceuticals Ltd

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous Improvements of outcomes after an autologous cartilage tissue implantation, compared with microfracture for treatment of distal femoral cartilage lesions.

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

	All versions	This version
Views	109	108
Downloads	0	0
Data volume	0 Bytes	0 Bytes

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous Improvements of outcomes after an autologous cartilage tissue implantation, compared with microfracture for treatment of distal femoral cartilage lesions.

Authors/Creators

Description

Files

Restricted